Article

Chase finalizes Unicorn deal, expands line

Chase Card Services, a division of JPMorgan Chase & Co., has finalized the acquisition of Unicorn Financial Services, a financing company for health-care patients.

Wilmington, DE-Chase Card Services, a division of JPMorgan Chase & Co., has finalized the acquisition of Unicorn Financial Services, a financing company for health-care patients. The combined company officially has launched its expanded set of patient financing products as ChaseHealthAdvance financing options.

Increasing medical and dental costs have created a need for new and adaptive health-care financing options, according to the company. In addition, the demand for elective procedures-dental, vision correction, and cosmetic, as well as veterinary care for pets-is increasing rapidly.

"Chase is able to offer affordable, flexible options for those looking to finance health-care procedures, as well as provide competitive service fees for providers," said Hugh Bleemer, general manager, ChaseHealthAdvance.

For more information on Chase-HealthAdvance financing options, visit http://www.chasehealthadvance.com/.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.